Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells - PubMed (original) (raw)
. 2009 Apr 9;28(14):1682-93.
doi: 10.1038/onc.2009.23. Epub 2009 Mar 2.
Affiliations
- PMID: 19252523
- DOI: 10.1038/onc.2009.23
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells
G Tilman et al. Oncogene. 2009.
Abstract
Most human tumor cells acquire immortality by activating the expression of telomerase, a ribonucleoprotein that maintains stable telomere lengths at chromosome ends throughout cell divisions. Other tumors use an alternative mechanism of telomere lengthening (ALT), characterized by high frequencies of telomeric sister chromatid exchanges (T-SCEs). Mechanisms of ALT activation are still poorly understood, but recent studies suggest that DNA hypomethylation of chromosome ends might contribute to the process by facilitating T-SCEs. Here, we show that ALT/T-SCE(high) tumor cells display low DNA-methylation levels at the D4Z4 and DNF92 subtelomeric sequences. Surprisingly, however, the same sequences retained high methylation levels in ALT/T-SCE(high) SV40-immortalized fibroblasts. Moreover, T-SCE rates were efficiently reduced by ectopic expression of active telomerase in ALT tumor cells, even though subtelomeric sequences remained hypomethylated. We also show that hypomethylation of subtelomeric sequences in ALT tumor cells is correlated with genome-wide hypomethylation of Alu repeats and pericentromeric Sat2 DNA sequences. Overall, this study suggests that, although subtelomeric DNA hypomethylation is often coincident with the ALT process in human tumor cells, it is not required for T-SCE.
Similar articles
- Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions.
Yehezkel S, Segev Y, Viegas-Péquignot E, Skorecki K, Selig S. Yehezkel S, et al. Hum Mol Genet. 2008 Sep 15;17(18):2776-89. doi: 10.1093/hmg/ddn177. Epub 2008 Jun 16. Hum Mol Genet. 2008. PMID: 18558631 - DNA methyltransferases control telomere length and telomere recombination in mammalian cells.
Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. Gonzalo S, et al. Nat Cell Biol. 2006 Apr;8(4):416-24. doi: 10.1038/ncb1386. Epub 2006 Mar 26. Nat Cell Biol. 2006. PMID: 16565708 - Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T, Guittat L, Stewart SA. Nittis T, et al. Biochimie. 2008 Jan;90(1):5-12. doi: 10.1016/j.biochi.2007.08.009. Epub 2007 Sep 2. Biochimie. 2008. PMID: 17935854 Review. - Telomere exchange and asymmetric segregation of chromosomes can account for the unlimited proliferative potential of ALT cell populations.
Blagoev KB, Goodwin EH. Blagoev KB, et al. DNA Repair (Amst). 2008 Feb 1;7(2):199-204. doi: 10.1016/j.dnarep.2007.09.012. Epub 2007 Nov 19. DNA Repair (Amst). 2008. PMID: 18006387 - Telomere length maintenance--an ALTernative mechanism.
Royle NJ, Foxon J, Jeyapalan JN, Mendez-Bermudez A, Novo CL, Williams J, Cotton VE. Royle NJ, et al. Cytogenet Genome Res. 2008;122(3-4):281-91. doi: 10.1159/000167814. Epub 2009 Jan 30. Cytogenet Genome Res. 2008. PMID: 19188697 Review.
Cited by
- The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres.
Graham MK, Xu B, Davis C, Meeker AK, Heaphy CM, Yegnasubramanian S, Dyer MA, Zeineldin M. Graham MK, et al. Cancer Res Commun. 2024 Jun 20;4(6):1533-1547. doi: 10.1158/2767-9764.CRC-22-0287. Cancer Res Commun. 2024. PMID: 38837897 Free PMC article. - Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention.
de Bardet JC, Cardentey CR, González BL, Patrone D, Mulet IL, Siniscalco D, Robinson-Agramonte MLA. de Bardet JC, et al. BioTech (Basel). 2023 Jan 28;12(1):14. doi: 10.3390/biotech12010014. BioTech (Basel). 2023. PMID: 36810441 Free PMC article. Review. - Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
Gao J, Pickett HA. Gao J, et al. Nat Rev Cancer. 2022 Sep;22(9):515-532. doi: 10.1038/s41568-022-00490-1. Epub 2022 Jul 5. Nat Rev Cancer. 2022. PMID: 35790854 Review. - Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.
Hou K, Yu Y, Li D, Zhang Y, Zhang K, Tong J, Yang K, Jia S. Hou K, et al. Cancers (Basel). 2022 Apr 27;14(9):2194. doi: 10.3390/cancers14092194. Cancers (Basel). 2022. PMID: 35565323 Free PMC article. Review. - Detection of alternative lengthening of telomeres mechanism on tumor sections.
Claude E, de Lhoneux G, Pierreux CE, Marbaix E, de Ville de Goyet M, Boulanger C, Van Damme A, Brichard B, Decottignies A. Claude E, et al. Mol Biomed. 2021 Oct 20;2(1):32. doi: 10.1186/s43556-021-00055-y. Mol Biomed. 2021. PMID: 35006465 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources